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Abstract:  
Abdominal aortic aneurysms (AAAs) are known as a dilation of the abdominal aorta and 
often have no symptoms; due to this lack of symptoms, many go undiagnosed and as a result, 
approximately 15,000 Americans die each year due to AAA rupture. In order to develop a better 
method of detection, mice aorta samples were collected and analyzed with FT-IR 
microspectroscopy; the aorta samples included healthy aortas as well as induced AAAs. A 
chemical algorithm was written using MATLAB so that the data may be most efficiently 
analyzed, and a chemical difference could be determined between the healthy and diseased 
tissue. However, before the chemical algorithm is able to analyze the data, it first needed to be 
validated. Amino acid copolymers were synthesized as biochemical standards to test the 
algorithm. With the initial biochemical standards available, the algorithm has proved to be 
functioning properly, although further tests are needed. Determining a chemical difference 
between the healthy and diseased tissue will lead to the ultimate goal of developing a non-
invasive tool for AAA detection. 
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Introduction:  
Abdominal aortic aneurysms (AAAs) are often difficult to detect due to a lack of 
symptoms, and as a result, 15,000 people die each year of an AAA rupture in the United States 
alone.
1
 An aneurysm “can be defined as a permanent and irreversible localized dilatation of a 
vessel”; an enlarged abdominal aorta is deemed an aneurysm once it has reached 1.5 times its 
normal diameter.
2
  As shown in Figure 1, a true aneurysm involves all three layers of the aortic 
wall: adventitia, media and intima.
3
 However, it is possible for only the adventitia layer to 
expand; it is considered a pseudoanuerysm, or false aneurysm, and it creates a separate pathway 
allowing blood flow.
3
 
 
Figure 1. Types of aortic aneurysms.
3
 
 AAAs are often difficult to detect because they have little to no symptoms, and as a 
result, many individuals are not aware of their impending aneurysm or its possibility of rupture.
1
 
As the aneurysm grows, it causes portions of the arterial wall to thicken and other portions to 
weaken, as well as a shift in the collagen-elastin ratio.
2
 There are two types of collagen that 
maintain the strength and structure of the arterial wall: collagen I and collagen III; the 
viscoelastic properties of the aorta are maintained by elastin and associated proteins, together 
forming elastic fibers.
2
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Figure 2. Normal aorta (left) and AAA (right).
4
  
A shift in the collagen-elastin ratio changes the nature of the arterial wall, exposing some areas 
to be weakened or thin. With enough weakening, the wall will rupture, in which case medical 
attention must be sought immediately. “The overall mortality rate for patients with ruptured 
abdominal aortic aneurysms is between 65% and 85%, and about half of deaths attributed to 
rupture occur before the patient reaches the surgical room”.2 
Currently the direct causes of AAAs are unknown; however, there are several risk factors 
that have been linked to the development of AAAs. The most prominent risk factor is tobacco 
use; in fact, “the prevalence of abdominal aortic aneurysms in tobacco smokers is more than four 
times that in life-long nonsmokers”.2 Additional risk factors include a person’s age and gender.2  
“The average age at the time of diagnosis is 65-70 years, and more men than women are 
affected”.3 Other risk factors include hypertension, hyperlipidaemia, chronic obstructive 
pulmonary disease and a family history of AAAs.
2
 
 These risk factors may be indicative of an AAA, but it can be difficult to diagnose 
because it has very few to no symptoms. An AAA can be diagnosed using a stethoscope and 
listening for the sounds of turbulent blood flow in the abdominal aorta; however this method is 
not always conclusive, and it is less effective in patients that are overweight.
1
 Detection of an 
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AAA is mostly commonly achieved using imaging techniques such as an ultrasound, computed 
tomography (CT) scan, or magnetic resonance imaging (MRI).
3
 CT scans are preferred because 
they are widely available and the images can be collected and interpreted within minutes.
3
  
 Once the AAA has been detected, there are several avenues for treatment. If the AAA is 
detected early in its development, physicians will encourage lifestyle changes, most importantly 
being cessation of tobacco use, in order to prevent further growth and rupture. Patients may also 
be prescribed non-steroidal anti-inflammatory drugs, statins, and pharmacologic inhibitors of 
matrix metalloproteinases (MMP), as these degrade collagen and elastic fibers.
2
 A recent study 
has also shown that Angiotensin II inhibitors have been effective in slowing AAA progression.
5
 
Lastly, a physician will recommend surgery; however, this greatly depends on the stage of the 
AAA and the amount of risk factors because surgery poses a great risk to the patient.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Management of an asymptomatic abdominal aortic aneurysm.
2
 
Asymptomatic abdominal aortic aneurysm  
< 4.5 cm 
Follow-up 
Ultrasonography 
every 6 months 
4.5 – 5.0 cm 
Follow-up 
Ultrasonography 
every 3 months 
or 6 months 
5.0 – 5.5 cm 
Follow-up 
Ultrasonography 
every 3 months 
or 6 months 
Surgery  
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endovascular  
repair if:  
> 5.5 cm 
Surgery 
Open or 
endovascular 
repair 
 
• Female patients 
• Familial cases 
• “Proved” rapid growth 
• Positive PET scan 
• High serum markers 
(such as MMP-9) 
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Elective aneurysm repair has greatly improved in recent years. Essentially this current 
form of repair includes placing an endograft around the aneurysm. While it can vary depending 
on the hospital and surgeon, the “mean 30-day mortality rate has been reported at between 1.1% 
and 7.0%”.2  There is also a new treatment being researched that has signs of being safer and just 
as effective as conventional surgery.
6
 A stent-graft device is placed in the area of the aneurysm 
though the use of a catheter.
6
 The stent-graft device is attached to the catheter which enters the 
aorta through the femoral artery. Once the catheter reaches the aneurysm, the stent-graft design is 
released, causing it to bind to the walls of the aorta. It has shown promising results including less 
blood loss, lower recovery time and lower morbidity than conventional surgery.
6
  
However, the key detail to elective aneurysm repairs, whether surgery or stent-graft 
inserted by catheter, is the awareness of the aneurysm to the individual. As mentioned before, 
there are very few to no symptoms associated with AAAs. Symptoms can present themselves 
with rupture of the aneurysm, but those symptoms “frequently are confused with those of 
appendicitis, pancreatitis, or bowel obstruction”.3 If the individual is able to seek immediate 
medical assistance, the outcome is still uncertain, as the mortality rate of emergency repair of a 
ruptured AAA is between 30-70%.
2
 And “unlike coronary heart disease, the incidence of AAA is 
reported to be increasing in Western Countries”.5  
Currently, screening for AAA occurs primarily in individuals that have a family history 
of the disease. However, only 1-5% of patients with AAA have a family history of the disease.
5
 
As there are no direct connections to AAAs and other health conditions, only risk factors, it 
would be quite impractical to screen every person who demonstrates a risk factor of an AAA. 
Therefore, it is crucial to create a better method of AAA detection. In order to improve current 
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methods, it would ideal to create a method that is fairly noninvasive, but more importantly, can 
become a routine procedure.  
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Preliminary Studies and Work: 
 There have been several studies that explored the various causes and chemical 
compositions of AAAs. For instance, a study conducted in 1995 used laser-induced florescence 
(LF) to examine the atherosclerotic plaque composition in aorta tissue samples. Dogs were 
injected with several compounds including collagen I, III and IV, elastin and cholesterol; it was 
after the injection of the listed compounds, the researchers observed a great change in the LF 
intensity. This study demonstrated that LF is a valuable method for determining chemical 
composition of plaque, but it also indicated that these compounds are in some way involved with 
plaque accumulation in both the thoracic and abdominal aorta.
7
 
 A separate study focused on the chemical difference of inflammatory abdominal aortic 
aneurysms (IAAAs) and AAAs by analyzing tissue samples through light microscopy, 
immunohistochemistry, and transmission electron microscopy (TEM). Through these methods, it 
was determined that a large quantity of B lymphocytes were present in an IAAA as well as 
deposits of IgG, IgM, and C3c in the interstitial matrix. Lastly, there was “an increase in type III 
collagen and a reduction in elastin,” suggesting the IAAA has a different development process 
than a typical AAA.
8
 
 In order to determine a chemical difference between a healthy aorta and aneurysm, aortic 
tissue samples were collected from mice and analyzed using Fourier Transform Infrared (FT-IR) 
microspectroscopy, prior to the author’s contribution on this project.1 “This study used 
apolipoprotein E (apoE) knockout mice ranging in age from 2 – 12 months”.9  The experimental 
group of mice were injected with angiotensin II to induce the aneurysm, a common procedure in 
cardiovascular research of animals.
9, 10
  
                                                             
1 “All procedures involving animals were approved by the Animal Care and Use Committee at the 
University of Kentucky”.9 
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Two mm pieces from above (ak) and from below (bk) the kidney branch 
of the aorta from both an experimental mouse (x) and a control mouse (c) 
were frozen in OCT (Optimal Cutting Temperature compound).  The 2 
mm pieces were sequentially sectioned from top to bottom, taking 12 
consecutive 5 µm slices from above and below the kidney in each mouse, 
resulting in 48 total samples (x-ak-1 to 12, x-bk-1 to 12, c-ak-1 to 12, 
and c-bk-1 to 12).  These samples were mounted on two low-e glass 
slides (SensIR) for 2-D FTIR reflectance spectrometry.
9
   
FT-IR microspectroscopy was chosen as the method of analysis because it a common yet 
effective method for identification of chemical composition. The common procedure for IR 
spectroscopy involves a sample is placed onto a salt plate, most common being sodium chloride 
or potassium bromide, and infrared light shines through the sample. When molecules are 
bombarded with light, they absorb some of the energy of that wavelength of light and express 
that energy. In the case of infrared light, the bonds between the atoms of molecules will increase 
their vibrational frequencies. Different types of bonds absorb different wavelengths of light and 
thus vibrate at different frequencies; these vibrations are recorded by the spectrometer, and a 
bond can be identified by the frequency and intensity of that vibration, ultimately leading to the 
identification of the molecule. The recorded vibrations are represented as a spectrum plotted as 
absorption against energy, which is the form of the data that will be analyzed in this study.  
While this method is useful for qualitative analysis of the aortic tissue, it collects a 
substantial amount of data, as further explained in the next section. In order to competently 
analyze this data, an efficient method needed to be created, which is where the author’s work 
begins.  
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Chemical Algorithm: 
 FT-IR microspectroscopy yields both special and spectra data. These datasets are often 
very large, creating significant challenges in analyzing experimental results. Figure 4 shows the 
image for one of the control mice above kidney cross-sections; this image is unique in that it is 
two-dimensional when the dataset is actually three-dimensional. The image shows the 
dimensions correspond to the length and width of the actual cross-section; the remaining 
dimension is the absorbance spectra from FT-IR microspectroscopy. In Figure 4, the absorbances 
of all energies in a specific pixel has been summed to give areas of high absorbance (blue) and 
areas of low absorbance (red), essentially showing the outline of the cross-sections.  
The image is divided into what can be called pixels, similar to a normal photograph.  
However, instead of the pixel being a mixture of three colors like that of a photograph, the pixel 
is composed of an infrared spectrum. The values along the axes are pixel counts, therefore there 
are 6600 spectra for only the cdataak1 dataset. Figure 5, also a total absorbance image, shows 
that the xdataak1 dataset has over 12,000 spectra to be analyzed due to the experimental mice 
aortic cross-section being much larger than the control mice. With this amount of data, a better, 
more efficient method of analysis needed to be developed.  
17 
 
 
Figure 4. Total absorbance image of control data above kidney 1 (cdataak1). 
 
Figure 5. Total absorbance image of experiment data above kidney 1 (xdataak1). 
 Prior to writing the algorithm, the total absorbance images were created by taking the 
sum of the third (spectral) dimension. The data was originally not in this configuration when it 
was exported from the instrument. If the data were in the shape of a cube, the x and y dimension 
would be the length and width, respectfully, and the z dimension would be the amount of 
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wavenumbers used in the infrared light spectrum; for these samples, and spectrum was taken at 
every eighth wavenumber, creating a total of 411 wavenumbers in the z dimension. However, 
data received from the instrument was two dimensional: (x ∙ y) by z. For example, the data 
received from cdataak1 was 6600 by 411. The instrument reports data in this way because it 
takes the spectra down a row, not necessarily all at once, and move to the next column after the 
row is completed.  
As a result, the data of each x row is placed adjacent to each other into one long line of 
data, and the absorbance values fill the second dimension. In order to convert the data into a 
three-dimensional dataset, a loop first needed to be written that could manipulate the data into 
this form. Once it was in this three dimensional form, the total absorbance images were created. 
As the author was a novice to MATLAB
® 
when starting this project, this beginning stage 
allowed adequate time and use to learn MATLAB
®
 to a comfortable degree. After this stage, the 
chemical algorithm could be written.  
The algorithm was written using MATLAB
®
, and due to the amount of data, it was 
determined that principal component analysis (PCA) and Mahalanobis distances would be the 
best methods to implement in the chemical algorithm for analyzing this aortic data. This 
combination of PCA and Mahalanobis distances has had previous success for analysis of 
gamma-ray flux car emissions; the instrument in question, a radiation portal monitor (RPM) and 
is used to first detect illicit nuclear material through its gamma-ray flux emissions and second, 
determine the location of that material in/on the vehicle. However, there are also benign gamma-
ray emissions from vehicles that can trigger the RPM. The researchers collected signatures of 
benign gamma-ray emissions and used these signatures for comparison in a screening. By using 
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PCA and Mahalanobis distances, the RPM is able to determine which gamma-ray emissions are 
benign and which should cause alert, making the monitor useful.
11
  
PCA is a method to reduce or simplify a dataset by “finding relationships between 
objects”.12 In other words, PCA will compare the data within a system to one another, and based 
on the amount of variance, rank them in order of greatest to least variance. Based on this ranking, 
PCA will output a new dataset for the original set of objects. The vectors of this matrix are called 
score vectors and loading vectors, and together these make a PC. The PC is then used as a 
dimension. Figure 6 shows an arbitrary plot of the first PC plotted against the second PC.  
 
Figure 6. Example of generated PC comparison plot. 
For the purpose of this example, the individual points can be considered IR spectra, with each 
point being a separate spectrum; the points are therefore color-coded based on the tissue sample. 
The data (or samples) that are most similar to each other will be plotted closer together, forming 
a cluster. In order to quantitatively measure the difference between these points, a Mahalanobis 
distance is used.  
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 The Mahalanobis distance formula was considered along with the Euclidean distance 
formula for measuring distance between points; however, it was determined to be the better 
formula, as explained below. A specific spectrum will be chosen, which will be from here on 
referred to as the point of interest (POI). It will be used as the reference point from which all 
other points will be measured. In this sense, if the POI is the spectrum for molecule X, then the 
algorithm will measure the distances from the POI to the remaining points and determine which 
are chemically most similar and different to molecule X. When the algorithm has computed the 
PCA and Mahalanobis distances, it will return the results in a false color image based upon the 
calculated value; the color spectrum is shown in Figure 7. The dark blue end of the spectrum 
originally represented little to no difference to the POI, and dark red represented significant 
chemical difference.  However, the gradient was later modified so that the reference is centered. 
It is important to identify negative and positive distances from the standard so the original false 
color gradient was modified. More detailed the reasoning is explained in the Creation of 
Biochemical Standard section.  
 
Figure 7. False-color gradient of Mahalanobis distances. 
Euclidean distances (Equation 1) were also considered as a method of measurement, but 
there is one important piece missing from its formula. As shown below, the Mahalanobis 
distance formula (Equation 2) incorporates the standard deviation into the formula, so it returns 
the values in relation to a standard deviation.  
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Equation 1. Euclidean distance.  
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Equation 2. Mahalanobis distance.  
Therefore, the Mahalanobis distance formula is capable of more accurately measuring a cluster 
that is not a perfect circle. Using Figure 8 as an example, the Euclidean distance formula would 
result in the vertical barriers to be a distance x, and the horizontal barriers to be a distance 2x. 
However, both the horizontal and vertical barriers are considered within the first standard 
deviation using the Mahalanobis distance formula.  
 
Figure 8. Example of generated PC comparison plot. 
 While this program is able to measure the statistical chemical difference between the 
different spectra, it is useless unless the spectrum of the POI is a known component. For 
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instance, the amount and location of collagen I can be determined in an aortic cross-section 
sample if the spectrum for collagen I is inserted as the reference or POI. It will return an image 
similar to that in Figures 4 and 5, but the false color gradient will represent the statistical 
difference from the collagen I.   
The false color gradient provides a solution to an interesting problem with this algorithm. 
As previously said, the PCA program returns a new dataset in the form of PCs, with the variance 
within the dataset ranked from greatest to least variance. The majority of variances will be 
provided in the first few PCs. Therefore, the best comparison of the data would include more 
than the first two PCs; however, there is currently no way to visually represent a fourth 
dimension on a two-dimensional surface. The false color gradient is able to incorporate the 
fourth dimension and beyond into its comparison; those PCs need only be selected when running 
the chemical algorithm. Lastly, the algorithm also uses the MATLAB
®
 functions reshape and 
imagesc to organize the Mahalanobis distance values and create the false-color image, 
respectfully.  
 
  
23 
 
Creation of Biochemical Standard: 
 Despite previously documented success with using PCA and Mahalanobis distances in 
analyzing large datasets, the chemical algorithm needed to be validated prior to analyzing the 
aortic tissue data. It was determined in order to most effectively test the algorithm, it would be 
best to use a material similar to the material that will ultimately be analyzed: the aortic tissue. As 
collagen and elastin are both known major components of the arterial wall, the building blocks, 
amino acids, were used for creating a biochemical standard. The process for creating the standard 
started by using four amino acids: glycine, L-proline, L-leucine, and L-valine. Glycine and L-
proline were chosen because collagen generally consists of one-third glycine and one-sixth L-
proline. L-leucine and L-valine were chosen because the IR spectra for each were quite similar 
(Figures 9 and 10); by using amino acids with similar IR spectra, it allowed the algorithm to be 
more greatly tested and determine potential limitations. 
    
Figure 9. Structure and FT-IR spectrum of L-leucine. 
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Figure 10. Structure and FT-IR spectrum of L-valine. 
The initial standards were mixtures of the amino acids in various simple ratios. Two 
amino acids were used in a mixture set, but the composition of each amino acid would change 
between samples in the set. Below is an example of a tested dataset of glycine and L-leucine. 
Figure 11 shows the spectra of the mixtures and the percentage composition of each; for this set, 
the molar ratio changed by 25% with mixtures ranging from 100% glycine (Gly) to 100% L-
leucine (Leu). The 50:50 mixture of glycine and L-leucine did saturate the instrument, but the 
mixture was still analyzed in order to determine initial success.  
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Figure 11. FT-IR spectra of glycine : L-leucine mixtures.  
It should be noted that there are three spectra for each sample. The original procedure 
required pressing the amino acid mixture onto a sodium chloride salt plate with a microspatula; 
this procedure was used because the best solvent for many amino acids is water, which cannot be 
used as a solvent for IR spectroscopy. With this procedure, it was found that the layer of mixture 
on the salt plate would not always be even, despite best efforts. To account for the variability in 
the samples, three spectra of each sample were taken. Once a sample was “plated”, a spectrum 
was taken; then the salt plate would be rotated approximately 120
°
 and another spectrum was 
taken. The process was repeated to reach a full circle and yielding three spectra per sample.  
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When the spectra were analyzed with the algorithm, L-leucine was used as the POI by 
calculating the average of the three L-leucine spectra. Figure 12 shows the false-color image that 
is generated by the algorithm to portray the results, and the Mahalanobis distance values are 
presented in Figure 13. As it can be determined, Figures 12 and 13 consist of only the first PC, 
but Figure 12 shows that the program was successful in ranking the chemical composition in 
terms of similarity; the algorithm impressively ranked the 50 Gly : 50 Leu mixture correctly as 
well.  
 
Figure 12. False-color image generated by the algorithm of glycine and L-leucine mixtures. 
 
Figure 13. Plot of first PC of glycine and L-leucine mixtures. 
The results given in Figures 12 and 13 were positive initial results. It was realized that the 
false color gradient did not best represent the chemical difference; it essentially showed the 
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chemical difference in one “dimension”. To give an example, if collagen I, collagen III and 
elastin were inserted into the algorithm, and collagen I was the POI, the results would indicate 
that collagen III and elastin were both on the opposite end of the spectrum to show the difference 
from the POI. However, these results would also indicate that collagen III and elastin are similar, 
which in fact, they are not. Because of this problem, the algorithm was adjusted to place the POI 
in the center of the false color gradient, representing a light green color as shown in Figure 14. 
With this new configuration, collagen III and elastin would be on opposite ends of the spectrum, 
assuming that collagen I is still the POI. Following this initial test, it was determined that the 
data, or mixtures, needed to be more complex to further test the algorithm. The next step was to 
make more complicated mixtures and to synthesize an amino acid copolymer. 
 
 
minimum            0                 maximum 
Figure 14. Modified false-color gradient of Mahalanobis distances. 
The synthesis of an amino acid copolymer first enlisted the use of a microwave. A 
synthesis of polyglycine was previously achieved by allowing the glycine to react at 140 
°
C for 
19 hours in aqueous ammonia.
13
 The time length was not desirable, thus a similar procedure was 
created based on this synthesis; however, it employed the time-saving capabilities of a 
microwave reactor. The first reaction consisted of glycine and water held at 150 
°
C for ten 
minutes, but it was unsuccessful. This procedure was modified many times, as show in Table 1.
14
 
The various reaction conditions that were adopted from past syntheses were “converted” to a 
microwave reaction with the help of advisors and through the use of a research and development 
28 
 
guide on continuous flow reactions and microwave reactions.
15
 The name of each reaction 
correlates to the date of the reaction as well as the reaction conditions.   
29 
 
Table 1. Unsuccessful amino acid copolymer microwave reactions. 
 Solvent Conditions Microwave Conditions 
Name/Test 
Reagent 
Amount 
Solvent Catalyst Time Temp. (
°
C) 
2-6-12 0.5156 g Gly 
10 mL deionized 
water (DI H2O) 
N/A 10 min 150 
4-3-12 Plain 0.5626 g Gly 6.8 mL DI H2O N/A 10 min 150 
4-3-12 
w/HCL 
0.5816 g Gly 6.6 mL DI H2O 
Drop of 
12.1 N HCl  
10 min 150 
4-12-12 8mL 0.3991 g Gly 8 mL DI H2O N/A 10 min 150 
4-12-12 6 mL 0.3635 g Gly 6 mL DI H2O N/A 10 min 150 
4-12-12 4 mL 0.3670 g Gly 4 mL DI H2O N/A 10 min 150 
4-12-12 2 mL 0.3577 g Gly 2 mL DI H2O N/A 10 min 150 
5-31-12  
2 mL SA 
0.3500 g Gly 2 mL DI H2O 
Drop of 
12 M H2SO4 
1 hr 250 
6-19-12  
Test A 
0.4074 g Gly N/A N/A  10 min 150 
6-19-12  
Test B 
0.7566 g Gly N/A 
0.8 mL 85% 
H3PO4 
10 min 160 
6-20-12 
Test C 
0.4476 g Gly 2 mL THF 
Drop of 9 N 
H2SO4 
1 hr 250 
6-27-12  
Test B.2 
0.7652 g Gly N/A 
0.8 mL 85% 
H3PO4 
10 min 160 
7-5-12  
3G : 1L 
0.4503 g Gly 
0.2667 g Leu 
N/A 
0.8 mL 85% 
H3PO4 
10 min 160 
7-5-12 
1G : 1L 
0.3092 g Gly 
0.5288 g Leu 
N/A 
0.8 mL 85% 
H3PO4 
10 min 160 
7-5-12 
1G : 3L 
0.1210 g Gly 
0.6311 g Leu 
N/A 
0.8 mL 85% 
H3PO4 
10 min 160 
7-24-12  
~0.02 mol G 
1.5019 g Gly N/A 
0.4 mL 85% 
H3PO4 
15 min 170 
7-25-12 
Trial 8 
1.0000 g Gly 0.1 mL DI H2O 
0.3 mL 85% 
H3PO4 
15 min 170 
7-25-12  
Trial 11 
1.0035 g Gly N/A 
0.3 mL 85% 
H3PO4 
10 min 170 
7-25-12  
Trial 17 
1.3328 g Gly N/A 
0.3 mL 85% 
H3PO4 
15 min 160 
7-25-12 
Trial 18 
1.1093 g Gly N/A 
0.3 mL 85% 
H3PO4 
15 min 165 
7-25-12 
Trial 19 
1.2409 g Gly N/A 
0.3 mL 85% 
H3PO4 
10 min 165 
 
 Due to the lack of success with the microwave, a procedure with a reaction time of one 
hour was attempted following the exact procedure as stated in the literature. The reaction is given 
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in Scheme 1. Each “R” represents a specific side chain for each amino acid. For example, R for 
glycine is H.    
     
Scheme 1. Amino acid thermal copolymerization in phosphoric acid.
16
 
The first time this scheme was deemed successful, it was tested with three different mixtures and 
analyzed with both IR spectroscopy of and High-Performance Liquid Chromatography Time Of 
Flight Mass Spectrometry (HPLC-MS-TOF). The compositions of these mixtures are given in 
Table 2, including the mixtures that were repeated to ensure reproducibility after the initial 
successful reactions. The data for the “All Glycine” products are given in Figures 15, 16 and 17; 
the data for the remaining products can be found in Appendix B. It was at this point that a 
microwave reaction was eliminated and the reaction in Scheme 1 was used.  
 
Table 2. Successful amino acid thermal copolymerization in phosphoric acid. 
Name Reagent Amount 
Amount of 85% 
H3PO4 
All Gly (July) 2.2525 g Gly 0.6 mL 
2 Gly : 1 Leu (July) 
1.5016 g Gly 
1.3126 g Leu 
0.6 mL 
1 Gly : 2 Leu (July) 
0.7512 g Gly 
2.6249 g Leu 
0.6 mL 
All Gly (Aug) 1.1265 g Gly 0.3 mL 
2 Gly : 1 Leu (Aug) 
0.7506 g Gly 
0.6589 g Leu 
0.3 mL  
1Gly : 2 Leu (Aug) 
0.3772 g Gly 
1.3107 g Leu  
0.3 mL 
  
85% Phosphoric Acid 
170 °C, 60 min 
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The names of the mixtures correlate to the composition of the mixture as well as date of 
when the reaction was completed. While both reactions were completed roughly a week apart, 
the reactions occurred in different months, as indicated in the name. The IR spectra in Figure 15 
show that the July and August products are identical and the product is indeed different from the 
glycine starting product. There are characteristic differences around 3300 cm
-1
 and the area 
below 1000 cm
-1
. These differences are best explained by the broadening effect that occurs with 
increased hydrogen bonding, as expected with the copolymer product. Likewise, a dramatic 
increase in absorbance at 1650 cm
-1
 in these product spectra suggests the presence of a new 
amide carbonyl functional group, which is consistent with the expected copolymer product. 
 
Figure 15. FT-IR spectra of “All Glycine” products and glycine starting material. 
 The data provided by the HPLC-MS-TOF also shows that the product is a copolymer of 
glycine. First, the retention time of glycine is 1.405 min. The retention times of this product are 
1.545 minutes and 1.677 min, indicating that these products are larger and less polar than glycine 
alone. Additionally, the mass of the fragments correlate to very large chains. It should be noted 
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that the values 453 m/z and 359 m/z, are fragments that remained in the system from the 2 Gly : 1 
Leu product, and the 215 m/z value is a separate compound that remained in the column. 
However, the value 286 m/z correlates to a five glycine unit chain. It is assumed that the smaller 
peaks are fragments of larger chains.  
 
Figure 16. HPLC-MS-TOF All Glycine (July) data: retention time 1.545 minutes. 
  
Figure 17. HPLC-MS-TOF All Glycine (July) data: retention time 1.677 minutes. 
With a successful copolymer reaction established, the new standard mixtures could be 
created. As collagen is a known major component of the arterial wall, a polymer with a collagen-
like distribution of amino acids would serve as an excellent model system in this study. The 
amino acid mixtures described were formulated and referred to as a “mock collagen” due to their 
ratio of amino acids present. Since the composition of collagen is one-third glycine and one-sixth 
L-proline, these molar ratios were maintained throughout all mixtures; the structure for each is 
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given below. The remaining fifty percent consisted of amino acids from the various subgroups: 
acidic, basic, polar, nonpolar, aromatic, and thiol. The list of amino acid mixtures is given in 
Table 3; the remaining amino acid structures are given in Appendix C. 
 
Figure 18. Glycine. 
 
 
Figure 19. L-Proline. 
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Table 3. Mock collagen mixture composition. 
 
Mixture Name Amino Acid (s) Composition 
A 
L-Valine 
L-Leucine 
25% 
25% 
B 
L-Valine 
L-Leucine 
10% 
40% 
C 
L-Valine 
L-Leucine 
40% 
10% 
D 
L-Tyrosine 
L-Valine 
25% 
25% 
E 
L-Glutamic Acid 
 
50% 
F 
L-Glutamic Acid 
L-Valine 
25% 
25% 
G 
L-Glutamic Acid 
L-Leucine 
25% 
25% 
H 
L-Asparagine 
 
50% 
I 
L-Asparagine 
L-Leucine 
25% 
25% 
J 
L-Asparagine 
L-Valine 
25% 
25% 
K 
L-Cysteine 
 
50% 
L 
L-Cysteine 
L-Leucine 
25% 
25% 
M 
L-Cysteine 
L-Valine 
25% 
25% 
 
The data collection procedure involved taking IR spectra of both the unreacted and 
reacted mixtures. First, each amino acid in a designated mixture was allocated and placed in a 
test tube. Once all of the amino acids were allocated, the mixture was generously ground 
together using a mortar and pestle made of agate. The mixture was then stored in an uncapped 
vial and placed in a vacuum desiccator to dry overnight. IR spectra of the unreacted mixtures 
were taken prior to the reaction using a FT-IR spectrometer. As previously described, the 
samples were pressed onto a sodium chloride salt plate by using a microspatula; however, this 
method presented several issues.  
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First, the sample would not spread easily on the plate; it would take a considerable 
amount of time to spread the sample which meant more time exposing it to air and water vapor. 
Next, the mixture would not spread evenly. In order to address this, three scans would be taken 
of a single sample, as previously explained. The faults of this original method were realized prior 
to creating the mock collagen mixtures, which allowed time to find a better method. It was 
determined that a potassium bromide press would be the best solution. Potassium bromide, like 
sodium chloride, does not absorb infrared light. The press uses a considerably smaller amount of 
sample for the IR scan, and it presses dry KBr with the sample so that the sample is actually 
contained within the salt plate. It effectively lowers the time and exposure to water vapor, 
yielding better, cleaner spectra. To ensure the quality of the spectra, the salt plate is still rotated 
120
°
 once to have two spectra of the same sample.  
After the IR spectra had been collected of the unreacted mixtures, each mixture was 
reacted according to Scheme 1 to create “mock collagen” copolymers. Once cooled, the products 
were extracted from any starting material via water and dialysis tubing. The material was placed 
in dialysis tubing with a pore size diameter of 4.8 nm which holds molecular weights of 12,000 g 
and higher. The tubing was then placed in a beaker of deionized water with a magnetic stir bar to 
stir the water, with the water being refreshed every 20 minutes over a one hour period.  
Very dry products were needed to create KBr pellets and obtain IR spectra of these 
products, but obtaining anhydrous solid products was non-trivial. Originally, the excess water 
would be evaporated by blowing a stream of gaseous nitrogen onto the product, and then it 
would be placed in the vacuum desiccator for two to three days. When reacted mixtures were 
analyzed with IR spectroscopy, the peak definition of each spectrum greatly diminished. The 
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products had a very gummy texture, meaning too much water was retained during the drying 
process, which made it difficult to achieve well-defined spectra.  
In order to address this issue, a high vacuum drying apparatus was assembled, as shown 
in Figure 20. The sample, contained in a small, uncapped vial, is placed in the round-bottom 
flask (1). The vial is covered by a Kimwipe secured by wire in order to prevent the loss of 
product. The first round-bottom flask is connected to the second round-bottom flask via rubber 
tubing. The round-bottom flask (2) holds drying reagent phosphorus pentoxide, which is then 
connected a two-piece cold trap (3). The trap is submerged in a Dewar flask filled with dry ice 
and acetone. The final tube connects the cold trap to the high vacuum on the left. With minimum 
water residue in the sample upon commencing, it has been determined that it takes 6-8 hours 
within the drying apparatus to sufficiently dry a product.  
 
Figure 20. High-vacuum drying apparatus: 1 is a round-bottom flask containing sample; 2 is a 
round-bottom flask holding drying reagent; 3 is a two-piece cold trap submerged in a Dewar 
flask.   
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Validation of Chemical Algorithm:  
 The validation of the chemical algorithm was ideally to be completed with all of the 
mock collagen mixtures; however the delay in drying products only allowed for the L-asparagine 
mixtures to be analyzed. The mixtures compositions are given in Table 3, and they were made 
according to the method described above. Figure 21 shows the IR spectra of the unreacted 
mixtures, mixtures H, I and J. There are unexpected spectra features that appear between 2875 
and 1875 cm
-1
 which is normally an unabsorbing region; it is likely that these features are a 
result of fringing and/or scattering. Because there are only six spectra (seven including the 
reference), PCA was not used for the analysis of these samples. It is suggested that PCA be used 
with a minimum sample size of fifty as according to the literature.
17
 The reference spectra used 
for validation are a spectrum of the individual amino acid indicated. For each amino acid, two 
spectra were taken as according to the method previously described. These spectra were then 
averaged to be used as the reference.  
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Figure 21. FT-IR spectra of unreacted mixtures H, I and J.  
 The unreacted mixtures H, I and J were then analyzed with the algorithm, and the results 
are given in Figure 22. The L-valine reference is the seventh column, because it is the light green 
color, it confirms that the reference was centered in the in false-color gradient. The mixture J 
spectra are considered “closest” to the reference based on the color scheme; this is also the 
expected result because mixture J contains L-valine and the other mixtures do not. It was 
predicted that mixture I would be the next “closest” to the L-valine reference because mixture I 
contains L-leucine. As mentioned before, L-valine and L-leucine have very similar IR spectra 
because there is only one carbon difference between the two molecules. These results confirm 
this prediction. Lastly, mixture H was considered to be the most chemical different because it 
contains neither L-leucine nor L-valine, and the results agree with this prediction. Glycine was 
also used as a reference for the different sets of spectra (Appendix E). 
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Figure 22. False-color image generated by the algorithm of unreacted mixtures H, I and J 
spectra: L-valine reference. 
 
 These preliminary results of the unreacted mixtures were very promising, but the reacted 
mixtures still needed to be analyzed. It can be seen in Figure 23 that the reacted mixtures have 
much less defined peaks in the spectra. This is due to the broadening effect that occurs with 
hydrogen bonds. To demonstrate the transformation between the unreacted and reacted mixtures, 
the differences between the mixture H spectra were calculated and shown in Figure 24. It shows 
that there is a considerable greater amount of character in the unreacted spectra, and there is an 
appreciable amount of hydrogen bonding to compress some of the large peaks, especially from 
3100-2950 cm
-1
 and near 1650 cm
-1
.  
Mixture H Mixture I Mixture J Ref. 
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Figure 23. FT-IR spectra of reacted mixtures H, I and J.  
 
 
Figure 24. Difference of average unreacted mixture H and average reacted mixture H FT-IR 
spectra. 
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When the reacted mixtures spectra were analyzed with the algorithm, again using L-
valine as a reference, the results (Figure 25) were similar to the results of the unreacted mixtures 
spectra. The mixture containing L-valine were most similar to the L-valine reference. Next in 
order was the mixture containing L-leucine, and the mixture that contained neither L-valine nor 
L-leucine was the furthest away, or least similar, to the L-valine reference. However, when 
glycine was used as the reference, the results were the same. It was determined that the spectra 
did not display enough variance for the algorithm to discern the true difference between the 
copolymers and the reference. Instead, the algorithm likely relied on the amount of absorbance of 
the reference (Figure 26).  
 
Figure 25. False-color image generated by the algorithm of reacted mixtures H, I and J spectra: 
L-valine reference. 
 
Mixture H Mixture I Mixture J Ref. 
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Figure 26. FT-IR spectra of reacted mixtures H, I and J with glycine and L-valine reference 
spectra. 
 
 In order to address this issue, the variance within the spectra needed to be highlighted. 
The greatest amount of variance existed between 1600 and 450 cm
-1
, as represented in Figure 27. 
This selection was then used by the algorithm with L-valine as a reference. The results (Figure 
28) show that the algorithm correctly ranked the mixtures, and these mixtures were specific to 
only L-valine. The results with glycine reference are provided in Appendix E.   
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Figure 27. FT-IR selected spectra of reacted mixtures H, I and J. 
 
Figure 28. False-color image generated by the algorithm of reacted mixtures H, I and J selected 
spectra: L-valine reference. 
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Conclusion: 
 The initial results from the chemical algorithm support the hypothesis that the algorithm 
is working properly. It is able to accept a reference and use it as such for comparison. The 
algorithm results also suggest that PCA will be useful with larger dataset; as previously 
mentioned, it was inappropriate to use PCA due to the small number of spectra studied here. This 
rational is supported by the results shown in Figure 28. To obtain the results, the superfluous data 
was removed and a new dataset was created containing the largest variance of the original 
dataset. This is the purpose of PCA; therefore, when PCA is reinserted into the algorithm, it may 
prove to be functional.  
At the moment, the algorithm is unfortunately not prepared for analysis of the aortic 
tissue due to lack of testable data. While it was intended to have validated the algorithm at this 
point, the delay in establishing a copolymer reaction as well as a drying mechanism has greatly 
slowed the progress. However, the initial results do prove promising based on the completed 
testing, specifically the differentiation between L-valine and L-leucine. Hopefully it will continue 
to prove functional as testing continues. When more data becomes available, the metrics of 
validation success will also be determined.  
The algorithm was written specifically to analyze aortic tissue; however its function 
could be used also for other large datasets.  Because the operations take little time to execute, it 
also could be used in a setting where large sets of data are collected rapidly, such as a hospital 
radiology department. Though it was written to determine a chemical difference between the 
healthy aorta and the aneurysm, it could potentially also be used in a diagnostic setting. 
 Validation of the algorithm will allow commencement of the analysis of the aortic tissue. 
Ideally the control data will be used to establish a norm for composition of the healthy aorta. As 
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many molecules have been previously identified to be contained within the aortic wall, the 
algorithm will assist in establishing a known concentration of these molecules. The “norm” will 
then be used against the aneurysm to determine both chemical differences but also concentration 
differences. Significant differences will then be considered for a chemical marker that is 
indicative of an AAA. Ideally the chemical marker would exist both in the aneurysm and blood, 
and therefore it could be detected through a blood test. Once this chemical marker is established, 
the overall objective of this project may be achieved.   
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Appendix A. MATLAB
®
 Functions 
Contents 
Function A1 – prepdata  47 
Function A2 – optPCA 48 
Function A3 – massdat 49 
Function A4 – reshape 53 
Function A5 – imagesc  54 
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Function A1 – prepdata 
function data = prepdata (data) 
  
if min(min(data)) >= 0 && max(max(data)) >= 20, 
    if min(min(data)) == 0, 
        data = (data + 0.0001); 
    end 
    data = log(100./data); 
end 
  
if min(min(data)) <= 0, 
    data = (data - min(min(data)) + 0.0001); 
end 
  
data = mscorrect(data); 
data = zscore(data); 
  
assignin('base','zabsdata',data) 
  
  
  
end 
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Function A2 – optPCA 
function scores=optPCA(data,lv) 
  
%PCA Principal components analysis optimized 
%  PCA uses svd to perform pca on a data matrix. It is 
%  assumed that samples are rows and variables are columns.  
%  The input is the data matrix (data). Outputs are the scores 
%  (scores) and loadings (loads). 
tic 
a = 1; 
[m,n] = size(data); 
  
  if (lv > min([m n])) %& (plots ~= 0) 
    disp('Resetting lv to be equal to min([m n])') 
    lv = min([m n]); 
  end 
toc 
if n < m 
    cov = (data'*data)/(m-1); 
    [u,s,v] = svd(cov); 
    assignin('base','u',u)  %   outputs u to the workspace 
    assignin('base','s',s)  %   outputs s to the workspace 
    assignin('base','v',v)  %   outputs v to the workspace 
    u = 0; 
    s = 0; 
    cov = 0; 
  
    toc 
  
  
    %  Form the PCA Model Based on the Number of PCs Chosen 
    loads  = v(:,1:lv); 
    toc 
    scores = data*loads; 
    toc 
else, 
    [scores] = pca(data,0,0,lv); 
end 
  
assignin('base','scores',scores)    %   outputs scores to the workspace 
  
  
  
%figure 
%plot3 (scores(:,1),scores(:,2),scores(:,3),'b.'); 
  
%xlabel('PC1'); 
%ylabel('PC2'); 
%zlabel('PC3'); 
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Function A3 – massdat 
function [ output_args ] = massdat(rawdata,amountPCs,poi,width,height) 
%massdat is able to analyze a large quantity of data. It uses PCA and 
%Mahalanobis distances to decrease the amount of data based on variance, 
%then compare it to a reference, respectively.  
%   rawdata is the dataset to be analyzed 
%amountPCs is the amount of PCs that are to be included in the calculation 
%poi is the reference. The reference should be inserted as the final 
%column in the dataset 
  
correcteddata=prepdata(rawdata);%correct raw data 
p=(width)-1; 
scores=optPCA(correcteddata,p);%principal component analysis of corrected raw 
data; p principal components calculated 
arraylength=length(rawdata);%total number of pixels in image 
arraylength=width; 
if amountPCs==1%only 1 principal component desired 
    R=input('Which PC?  '); 
   pc=scores(:,R);%extract a column of scores from array generated by optPCA 
   %pc=correcteddata(:,R); %This line is available for small dataset (N<50) 
and should be inserted 
   %when PCA is not being used. 
   stdn=std(pc);%standard deviation of data points in specified PC 
    for i=1:1:arraylength%total number of points 
        mahaldist=(1/stdn)*(pc(i,:)-pc(poi,:));%mahalanobis 
distance=euclidean distances/standard deviation 
        if i==1 
            mahalanobisdistances=mahaldist;%create array 
        else 
            mahalanobisdistances=[mahalanobisdistances;mahaldist];%add to 
array 
        end 
    end 
    assignin('base','mahalanobisdistances',mahalanobisdistances); 
   sortedmahalanobisdistances=sort(mahalanobisdistances);%sort 
   assignin('base','sortedmahalanobisdistances',sortedmahalanobisdistances); 
   minimum=min(sortedmahalanobisdistances);%This centers the false-color 
scheme center iteself around the poi 
   maximum=max(sortedmahalanobisdistances); 
   if abs(minimum)>maximum%if the absolute value of the minimum distance 
value is greater than the maximum 
          clim(1,1)=minimum;%minimum value becomes lower limit 
          clim(1,2)=-minimum%opposite minimum value becomes upper limit 
   else clim(1,1)=-maximum;%otherwise, opposite max becomes lower limit 
       clim(1,2)=maximum;%max becomes upper limit 
   end 
   imagedata=reshape(mahalanobisdistances,width,1); 
   imagedata=imagedata'; 
   assignin('base','imagedata',imagedata); 
   imagesc(imagedata,clim); 
      colormap(jet) 
else if amountPCs>=2 
        %option1%indicate pcs by user interface control object 
        %option2 
        %firstPC=scores(:,option1);%column in scores 
50 
 
        %secondPC=scores(:,option2);%column in scores 
        %std1=STD(firstPC(:,1));%column standard deviation 
        %std2=STD(secondPC(:,1));%column standard deviation 
      %  R=input('Which PCs'); 
      %  if R=='all'   
      %    n=1:1:amountPCs;  
      %    assignin('base','n',n); 
      %  else if R~='all'  
      %          n=R; 
      %      end 
      %  end 
      %  for n=1:1:amountPCs%total number of PCs 
      
      reply=input('All PCs? Y/N [Y]:','s'); 
         if isempty(reply) 
             reply='Y'; 
            n=1:1:p; 
            %n=n'; 
           else reply='N'; %Only the PCs selectively entered will be 
compared. 
              chosenPCs=input('Enter a variable'); 
              chosenPCs=chosenPCs'; 
              assignin('base','chosenPCs',chosenPCs) 
              %chosenPCs=keyboard('Which PCs?') 
              y=length(chosenPCs); 
              n=(scores(:,chosenPCs));  
             % n=n'; 
               
         end 
          
         for i=1:1:arraylength%total number of points 
            PCn=scores(:,n); 
            assignin('base','PCn',PCn) 
            stdn=std(PCn(:,n)); 
            mahaldistn=(1/stdn)*(PCn(i,1)-PCn(poi,1));%column mahalanobis 
distances 
             if i==1 
            mahalanobisdistances=mahaldistn;%create array 
             else 
                mahalanobisdistances=[mahalanobisdistances;mahaldistn];%add 
to array 
             end 
             assignin('base','mahalanobisdistances',mahalanobisdistances) 
         end 
               
             %for j=1:1:arraylength%total number of points 
        %    mahaldist2=(1/std2)*(secondPC(j,1)-secondPC(poi,1));%column 
mahalanobis distances 
        %     if j==1 
        %    mahalanobisdistances2=mahaldist2;%create array 
        %     else 
        %        
mahalanobisdistances2=[mahalanobisdistances2;mahaldist2];%add to array 
        %    end 
        %end 
                for x=1:1:arraylength%total number of points 
51 
 
            vectorsum=sqrt(sum((mahalanobisdistances(x,1))^2));%sum 
components 
                if x==1 
            vectorsums=vectorsum;%create array 
                 else 
                vectorsums=[vectorsums;vectorsum];%add to array 
                end 
                end         
            
   assignin('base','vectorsums',vectorsums);      
   sortedvectorsums=sort(vectorsums);%sort 
   %clim(1,1)=sortedvectorsums(round(0.02*arraylength));%lower limit 
   %clim(1,2)=sortedvectorsums(round(0.98*arraylength));%upper limit 
   minimum=min(sortedvectorsums);%This centers the false-color scheme center 
iteself around the poi 
   maximum=max(sortedvectorsums); 
   if abs(minimum)>maximum%if the absolute value of the minimum distance 
value is greater than the maximum 
          clim(1,1)=minimum;%minimum value becomes lower limit 
          clim(1,2)=-minimum%opposite minimum value becomes upper limit 
   else clim(1,1)=-maximum;%otherwise, opposite max becomes lower limit 
       clim(1,2)=maximum;%max becomes upper limit 
   end 
   imagedata=reshape(vectorsums,width,height); 
   imagedata=imagedata'; 
   imagesc(imagedata,clim); 
   colormap(jet) 
    
            
        
   % else%if amountPCs==3 
   %     option1 
   %     option2 
   %     firstPC=scores(:,option1);%column in scores 
   %     secondPC=scores(:,option2);%column in scores 
   %     thirdPC=scores(:,option3);%column in scores 
   %     std1=STD(firstPC(:,1));%column standard deviation 
   %     std2=STD(secondPC(:,1));%column standard deviation 
   %     std3=STD(thirdPC(:,1));%column standard deviation 
   %     for i=1:1:arraylength%total number of points 
    %        mahaldist1=(1/std1)*(firstPC(i,1)-firstPC(poi,1));%column 
mahalanobis distances 
    %         if i==1 
    %        mahalanobisdistances1=mahaldist1;%create array 
    %         else 
    %            
mahalanobisdistances1=[mahalanobisdistances1;mahaldist1];%add to array 
    %        end 
    %    end 
    %    for j=1:1:arraylength%total number of points 
    %        mahaldist2=(1/std2)*(secondPC(j,1)-secondPC(poi,1));%column 
mahalanobis distances 
    %         if j==1 
    %        mahalanobisdistances2=mahaldist2;%create array 
    %         else 
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    %            
mahalanobisdistances2=[mahalanobisdistances2;mahaldist2];%add to array 
    %         end 
    %    end 
    %    for k=1:1:arraylength 
    %        mahaldist3=(1/std3)*(thirdPC(k,1)-thirdPC(poi,1));%column 
mahalanobis distances 
    %        if k==1 
    %            mahalanobisdistances3=mahaldist3;%create array 
    %        else 
    %            
mahalanobisdistances3=[mahalanobisdistances3;mahaldist3];%add to array 
    %        end 
    %    end 
    %    for x=1:1:arraylength%total number of points 
    %        
vectorsum=sqrt(((mahalanobisdistances1(x,1))^2)+((mahalanobisdistances2(x,1))
^2)+((mahalanobisdistances3(x,1))^2));%sum components 
    %        if x==1 
    %        vectorsums=vectorsum;%create array 
    %        else 
    %            vectorsums=[vectorsums;vectorsum];%add to array 
    %        end 
    %    end 
 %  assignin('base','vectorsums',vectorsums);      
 %  sortedvectorsums=sort(vectorsums);%sort 
 %  clim(1,1)=sortedvectorsums(round(0.02*arraylength));%lower limit 
 %  clim(1,2)=sortedvectorsums(round(0.98*arraylength));%upper limit 
 %  imagedata=reshape(vectorsums,height,width); 
 %  imagesc(imagedata,clim); 
 %  colormap(jet) 
 %  end 
        
     end 
end  
    
end      
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Function A4 – reshape 
%RESHAPE Reshape array. 
%   RESHAPE(X,M,N) returns the M-by-N matrix whose elements 
%   are taken columnwise from X.  An error results if X does 
%   not have M*N elements. 
% 
%   RESHAPE(X,M,N,P,...) returns an N-D array with the same 
%   elements as X but reshaped to have the size M-by-N-by-P-by-... 
%   M*N*P*... must be the same as PROD(SIZE(X)). 
% 
%   RESHAPE(X,[M N P ...]) is the same thing. 
% 
%   RESHAPE(X,...,[],...) calculates the length of the dimension 
%   represented by [], such that the product of the dimensions  
%   equals PROD(SIZE(X)). PROD(SIZE(X)) must be evenly divisible  
%   by the product of the known dimensions. You can use only one  
%   occurrence of []. 
% 
%   In general, RESHAPE(X,SIZ) returns an N-D array with the same 
%   elements as X but reshaped to the size SIZ.  PROD(SIZ) must be 
%   the same as PROD(SIZE(X)).  
% 
%   See also SQUEEZE, SHIFTDIM, COLON. 
  
%   Copyright 1984-2005 The MathWorks, Inc. 
%   $Revision: 5.14.4.5 $  $Date: 2009/05/18 20:48:03 $ 
%   Built-in function. 
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Function A5 – imagesc 
function h = imagesc(varargin) 
%IMAGESC Scale data and display as image. 
%   IMAGESC(...) is the same as IMAGE(...) except the data is scaled 
%   to use the full colormap. 
%    
%   IMAGESC(...,CLIM) where CLIM = [CLOW CHIGH] can specify the 
%   scaling. 
% 
%   See also IMAGE, COLORBAR, IMREAD, IMWRITE. 
 %   Copyright 1984-2005 The MathWorks, Inc. 
%   $Revision: 5.11.4.5 $ 
  
clim = []; 
switch (nargin), 
  case 0, 
    hh = image('CDataMapping','scaled'); 
  case 1, 
    hh = image(varargin{1},'CDataMapping','scaled'); 
  case 3, 
    hh = image(varargin{:},'CDataMapping','scaled'); 
  otherwise, 
  
    % Determine if last input is clim 
    if isequal(size(varargin{end}),[1 2]) 
      str = false(length(varargin),1); 
      for n=1:length(varargin) 
        str(n) = ischar(varargin{n}); 
      end 
      str = find(str); 
      if isempty(str) || (rem(length(varargin)-min(str),2)==0), 
        clim = varargin{end}; 
        varargin(end) = []; % Remove last cell 
      else 
        clim = []; 
      end 
    else 
      clim = []; 
    end 
    hh = image(varargin{:},'CDataMapping','scaled'); 
end 
  
% Get the parent Axes of the image 
cax = ancestor(hh,'axes'); 
  
if ~isempty(clim), 
  set(cax,'CLim',clim) 
elseif ~ishold(cax), 
  set(cax,'CLimMode','auto') 
end 
  
if nargout > 0 
    h = hh; 
end  
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Appendix B. Glycine and L-Leucine Copolymer FT-IR Spectra and HPLC-MS-TOF Data 
Glycine Retention Time: 1.405 min 
L-Leucine Retention Time: 1.497 min 
 
 
Figure B1. FT-IR spectra of 2 Gly : 1 Leu copolymers and starting reagents.  
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Figure B2. HPLC-MS-TOF 2 Gly : 1 Leu (July) data: retention time 1.518 minutes. 359 m/z 
correlates to a 3 Gly and 11 Leu chain. 
 
 
 
Figure B3. HPLC-MS-TOF 2 Gly : 1 Leu (July) data: retention time 1.699 minutes. 176 m/z 
correlates to an 8 Gly and 2 Leu chain. 
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Figure B4. HPLC-MS-TOF 2 Gly: 1 Leu (July) data: retention time 1.897 minutes. 176 m/z 
correlates to an 8 Gly and 2 Leu chain. 
 
 
Figure B5. FT-IR spectra of 1 Gly : 2 Leu copolymers and starting reagents. 
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Figure B6. HPLC-MS-TOF 1 Gly: 2 Leu (July) data: retention time 1.497 minutes. 105 m/z 
correlates to a 6 Gly and 1 Leu chain. 
 
 
Figure B7. HPLC-MS-TOF 1 Gly: 2 Leu (July) data: retention time 1.695 minutes. 176 m/z 
correlates to an 8 Gly and 2 Leu chain.  
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Figure B8. HPLC-MS-TOF 1 Gly: 2 Leu (July) data: retention time 1.893 minutes. 774 m/z 
correlates to a 3 Gly and 12 Leu chain.  
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Appendix C. Amino Acids 
 
L-Asparagine 
 
L-Cysteine 
 
L-Glutamic Acid 
 
Glycine 
 
 
L-Leucine 
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L-Proline 
 
L-Valine 
 
 
L-Tyrosine 
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Appendix D. Unreacted Mixture FT-IR Spectra 
For mixture compositions, see Table 3. 
 
Figure D1. FT-IR spectra of unreacted mixtures A, B and C.  
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Figure D2. FT-IR spectra of unreacted mixture D. Additional L-tyrosine mixtures were intended 
to be created, but there was not a sufficient amount of L-tyrosine available to create these 
mixtures. 
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Figure D3. FT-IR spectra of unreacted mixtures E, F and G.  
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Figure D4. FT-IR spectra of unreacted mixtures K, L and M. 
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Appendix E. Chemical Algorithm Results of Glycine Reference  
 
Figure E1. False-color image generated by the algorithm of unreacted  
mixtures H, I and J spectra: glycine reference. 
 
Figure E2. False-color image generated by the algorithm of reacted  
mixtures H, I and J selected spectra: glycine reference.  
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Mixture H Mixture I Mixture J Ref. 
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